BlackRock reveals that institutional demand for Bitcoin ETFs is driven more by financialization—using Bitcoin as collateral, for options, and lending—than by custody needs. Since launching the iShares Bitcoin ETF (IBIT) in January 2024, over $3 billion in Bitcoin has been converted into ETF shares, making Bitcoin more accessible within traditional portfolios. BlackRock also introduced the iShares Bitcoin Premium Income ETF (BITA) in June 2026, offering 15-25% yields through options strategies. This shift reduces Bitcoin's free-floating supply on exchanges and challenges competitors to enhance their financialization tools to stay competitive.
BlackRock's insights on Bitcoin ETFs provide context for cryptocurrency market trends. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Sep 18, 2026 21:36 WIB: out of 50 priced major cryptocurrencies, 46 rose and 3 fell today. Notable movers include XTZ (Tezos) at Rp4.883 with a 10.15% increase and a typical hold time of 100 days, DOT (Polkadot) at Rp20.185 up 9.96% with a 120-day hold time, and ONE (Harmony) at Rp31 rising 9.17% with a 154-day hold time. Pluang order activity shows strong buying interest in XTZ and DOT, while ONE sees predominantly selling activity.
Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...
Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...
Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...
Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...
Lennox's board approved a quarterly cash dividend of $1.36 per share, payable on October 15, 2026, to shareholders recorded by September 30, 2026. This dividend reflects Lennox's ongoing commitment to returning value to its investors. Lennox is a lea...
